CICR Steering Committee

Vice-President
Molecular Innovation
Indiana Biosciences Research Institute
Indianapolis, Indiana

Chief Scientific Oficer
ORIC Pharmaceuticals, Inc.
San Francisco, California

Principal Scientist
Discovery Chemistry
Genentech, Inc.
South San Francisco, California

Head, Therapeutic Innovation and Drug Discovery
Ontario Institute for Cancer Research
Toronto, Canada

Professor, Pharmaceutical Chemistry, School of Pharmacy
University of California San Francisco
San Francisco, California 

Associate Professor
Cancer Biology, Dana-Farber Cancer Institute
Biological Chemistry and Molecular Pharmacology
Harvard Medical School
Boston, Massachusetts

Vice-President
Protein Degrader Platform
Foghorn Therapeutics
Cambridge, Massachusetts

George P. Canellos, MD, and Jean S. Canellos Professor of Medicine
Harvard Medical School;
Chair of Medical Oncology
Dana-Farber Cancer Institute
Boston, Massachusetts

President
Chief Executive Officer
Interdict Bio
San Francisco, California

Director and Head of Medicinal Chemistry GER
Merck Healthcare KGaA
Darmstadt, Germany

Senior Director
C4 Therapeutics
Watertown, Massachusetts

Vice President
Triana Biomedicines
Lexington, Massachusetts

Vice President, Head of Chemistry
Foghorn Therapeutics
Cambridge, Massachusetts 

Professor of Chemical Biology
Department of Chemistry
University of California, Berkeley

Founder and Chief Innovation Officer
Arrakis Therapeutics
Waltham, Massachusetts

Head of Chemical Biology East Coast
Pfizer Inc.
Cambridge, Massachusetts

Head of China Innovation Center of Roche
Senior Vice President
Shanghai, China

Global Head Oncology and Immuno-Oncology Chemistry
Novartis Institutes for BioMedical Research (NIBR)
Brookline, Massachusetts